-
Featured
Using Genetics and Big Data to Determine Risk for Developing Glaucoma
Nazlee Zebardast, MD, MSc, director of Glaucoma Imaging at Mass Eye and Ear/Massachusetts General Hospital Department of Ophthalmology, discusses the use of big data to determine endophenotypes for disease in glaucoma.
-
Minimally Invasive Glaucoma Surgery Has Been Adopted Rapidly in the U.S.
Ophthalmologists at Massachusetts Eye and Ear/Massachusetts General Hospital have determined that between 2013 and 2018, the number of minimally invasive glaucoma surgeries surpassed the number of conventional glaucoma surgeries, despite limited evidence of long-term safety or effectiveness.
-
Using Technology to Assess Patient-recorded Outcomes in Glaucoma Treatment
David S. Friedman, MD, PhD, MPH, a clinician scientist and director of the Glaucoma Service at Mass Eye and Ear, discusses a pilot program to assess patient-reported outcomes for glaucoma treatment.
-
Using Artificial Intelligence to Diagnose Glaucoma
David S. Friedman, MD, PhD, MPH, a clinician-scientist and director of the Glaucoma Service in the Department of Ophthalmology, discusses the implementation of artificial intelligence in the detection of glaucoma in screening with photographs.
-
Advancing Treatments for Inherited Retinal Diseases
Rachel M. Huckfeldt, MD, PhD, at Mass Eye and Ear/Massachusetts General Hospital Department of Ophthalmology, discusses how she and her colleagues work collaboratively to better understand the genetic basis of inherited retinal diseases and work towards genetic treatments, including gene replacement and genome editing.
-
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
Milica A. Margeta, MD, PhD, and Janey L. Wiggs, MD, PhD, of the Mass Eye and Ear/Massachusetts General Hospital Department of Ophthalmology have demonstrated that the APOE ε4 allele, the strongest genetic risk factor for late-onset Alzheimer's disease, has a protective effect against primary open-angle glaucoma.
Glaucoma Contributors
-
David S. Friedman, MD, PhD, MPH
Director, Glaucoma Service, Albert and Diane Kaneb Chair in Ophthalmology, Mass Eye and Ear, Professor, Ophthalmology, Harvard Medical School
Recent Article
Using Technology to Assess Patient-recorded Outcomes in Glaucoma Treatment -
Janey L. Wiggs, MD, PhD
Associate Chief, Ophthalmology Clinical Research, Mass Eye and Ear, Paul Austin Chandler Professor of Ophthalmology, Harvard Medical School
Recent Article
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
-
Joseph B. Ciolino, MD
Physician and Surgeon, Mass Eye and Ear/Massachusetts General Hospital Department of Ophthalmology, Associate Professor, Ophthalmology, Harvard Medical School
Recent Article
Developing Drug-Releasing Contact Lenses
-
Milica Margeta, MD, PhD
Assistant Professor of Ophthalmology, Harvard Medical School, Assistant Scientist, Mass Eye and Ear
Recent Article
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
-
Nazlee Zebardast, MD, MSc
Director, Glaucoma Imaging, Mass Eye and Ear/Massachusetts General Hospital Department of Ophthalmology, Assistant Professor, Ophthalmology, Harvard Medical School
Recent Article
Minimally Invasive Glaucoma Surgery Has Been Adopted Rapidly in the U.S.
Mass Eye and Ear/Mass General Ophthalmology
An international center for ophthalmology treatment and research, Mass Eye and Ear/Massachusetts General Hospital is the primary teaching hospital of Harvard Medical School’s Department of Ophthalmology, and is consistently recognized as one of the nation’s top hospitals for eye care. Led by Chief and Chair Joan W. Miller, MD, the department provides seamless access to the most innovative care available anywhere in the world.
